Edwards Lifesciences (EW) Stock Research, Analysis & News

Quick Analysis on Edwards Lifesciences (EW) Stock as of September 20, 2017

Previous Closing Price $111.28 is below its 50 day moving average $113.80
Previous Closing Price $111.28 is above 200 day moving average of $109.37
The Price/Earnings To Growth ratio (PEG) is great than 1
The Stock pays no dividend
The closing price $111.28 is less than 17.54% away from its one year target price of $130.80
Current Short Ratio 1.54 is great than 1
(See more information about Edwards Lifesciences (EW) Stock below)

Edwards Lifesciences (EW) Stock Profile Summary

Edwards Lifesciences Corporation provides products and technologies designed to treat advanced cardiovascular diseases. It offers products and technologies for heart valve therapy, critical care, cardiac surgery systems, and vascular diseases. The company provides tissue heart valves, such as pericardial and porcine valves, as well as repair products, including annuloplasty rings and systems used to replace or repair a patient's diseased or defective heart valve. It also offers hemodynamic monitoring equipment that is used to measure a patient's heart function in surgical and intensive care settings; and disposable pressure transducers. In addition, the company provides cardiac surgery systems products, including cannulae, intra-aortic filtration system, and other disposable products used during cardiopulmonary bypass procedures; and vascular products that comprise balloon-tipped and catheter-based embolectomy products, surgical clips, and clamps to treat endolumenal occlusive disease. Edwards Lifesciences Corporation distributes its products through a direct sales force and independent distributors worldwide. It has a collaboration agreement with DexCom, Inc. to develop products for monitoring blood glucose levels in patients hospitalized for various conditions. The company was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences Corporation operates independently of Baxter International Inc., as of March 31, 2000.

Edwards Lifesciences (EW) Stock Key Statistics Research and Analysis as of September 20, 2017

Stock ExchangeNYQ
Market Capitalization$23.56B
Trade Volume (Average Trading Volume)527,855 (1,228,750)
Current Year EPS Estimate$3.78
Next Year EPS Estimate$4.18
Previous Closing Price$111.28
50 Day Price Moving Average$113.80
200 Day Price Moving Average$109.37
1 yr Target Price$130.80
PEG Ratio1.80
Short Ratio1.54

Edwards Lifesciences (EW) Stock Competitor Research and Analysis

Hospira Inc. (HSP)Medtronic, Inc. (MDT)
St. Jude Medical Inc. (STJ)Unitedhealth Group, Inc. (UNH)
WellPoint Inc. (WLP)Aetna Inc. (AET)

Mutual Funds with Edwards Lifesciences (EW) Stock in its top 10 holdings

FundCategoryEW Holding Percentage
Alger Health Sciences AHealth2.79%
Bright Rock Mid Cap Growth InstlMid-Cap Growth3.01%
Bridgeway Aggressive Investors 1Mid-Cap Blend2.35%
Dunham Small Cap Growth ASmall Growth1.16%
AllianzGI Mid-Cap DMid-Cap Growth2.45%
Dunham Small Cap Growth NSmall Growth1.16%

ETFs with Edwards Lifesciences (EW) Stock in its top 10 holdings

Stock Research on Edwards Lifesciences (EW)

Latest Market News on Edwards Lifesciences (EW)

Click here to find the latest news on Edwards Lifesciences (EW)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Hospira Inc. (HSP)
Medtronic, Inc. (MDT)
St. Jude Medical Inc. (STJ)
Unitedhealth Group, Inc. (UNH)
WellPoint Inc. (WLP)
Aetna Inc. (AET)